Agile Therapeutics (NASDAQ: AGRX)
|Date||Analyst Firm||Analyst Name||Action||Rating||Action Price||Prior Price||Target|
You can purchase shares of Agile Therapeutics (NASDAQ: AGRX) through any online brokerage.
The latest price target for Agile Therapeutics (NASDAQ: AGRX) was reported by Maxim Group on Friday, April 8, 2022. The analyst firm set a price target for 0.00 expecting AGRX to fall to within 12 months (a possible -100.00% downside). 4 analyst firms have reported ratings in the last year.
The stock price for Agile Therapeutics (NASDAQ: AGRX) is $1.39 last updated May 19, 2022, 8:00 PM UTC.
There are no upcoming dividends for Agile Therapeutics.
Agile Therapeutics’s Q2 earnings are confirmed for Monday, July 25, 2022.
There is no upcoming split for Agile Therapeutics.
Agile Therapeutics is in the Health Care sector and Pharmaceuticals industry. They are listed on the NASDAQ.